Benzinga · Sep 29, 2026
Needham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target
Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $101 price target.
NASDAQ · MMSI
Healthcare · Medical - Instruments & Supplies
$87.21
Up+$1.96 (+2.30%)
Updated Oct 10, 2026, 8:43 PM
SID Score
4.8/10
Composite research score
Smart Money
58/100
Neutral
Price performance · MMSI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
MMSI closed at $87.21 after 21 trading sessions, up 0.98% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $85.41 | $87.62 | $85.41 | $87.21 | 480.79K |
| Oct 8, 2026 | $85.02 | $85.81 | $83.94 | $85.25 | 579.4K |
| Oct 7, 2026 | $84.93 | $86.01 | $84.73 | $85.09 | 468.06K |
| Oct 6, 2026 | $87.45 | $88.90 | $84.22 | $84.96 | 587.66K |
| Oct 5, 2026 | $85.40 | $87.57 | $84.74 | $87.14 | 699.16K |
| Oct 2, 2026 | $86.73 | $86.855 | $85.24 | $85.37 | 492.41K |
| Oct 1, 2026 | $86.00 | $86.865 | $85.42 | $86.15 | 701.75K |
| Sep 30, 2026 | $87.87 | $88.23 | $86.23 | $86.23 | 634.2K |
| Sep 29, 2026 | $87.04 | $88.13 | $86.33 | $87.87 | 730.96K |
| Sep 28, 2026 | $87.20 | $88.09 | $86.57 | $87.00 | 551.09K |
| Sep 25, 2026 | $87.25 | $87.95 | $86.77 | $87.50 | 354.05K |
| Sep 24, 2026 | $87.18 | $87.56 | $86.445 | $87.30 | 743.29K |
| Sep 23, 2026 | $86.96 | $88.14 | $86.925 | $87.07 | 611.24K |
| Sep 22, 2026 | $86.03 | $87.79 | $85.47 | $87.26 | 682.78K |
| Sep 21, 2026 | $85.88 | $86.23 | $84.99 | $85.49 | 379.9K |
| Sep 18, 2026 | $85.03 | $87.33 | $84.12 | $85.37 | 910.44K |
| Sep 17, 2026 | $86.40 | $86.4974 | $85.23 | $85.57 | 319.37K |
| Sep 16, 2026 | $85.49 | $87.68 | $85.31 | $86.14 | 540.64K |
| Sep 15, 2026 | $86.81 | $86.81 | $85.655 | $86.18 | 533.15K |
| Sep 14, 2026 | $87.525 | $87.825 | $86.03 | $87.02 | 385.72K |
| Sep 11, 2026 | $87.49 | $88.195 | $85.40 | $86.36 | 443.19K |
The latest Smart Investors Daily articles mentioning MMSI.
Company
Market Activity
Research & News
MMSI research
Company profile and research snapshot.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 29, 2026 | Needham | Buy | — |
| Aug 13, 2026 | B of A Securities | Neutral | — |
| Aug 11, 2026 | BTIG | Buy | — |
| Aug 3, 2026 | Canaccord Genuity | Buy | — |
| Jul 31, 2026 | Piper Sandler | Overweight | — |
No generated briefing is available yet.
Benzinga · Sep 29, 2026
Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $101 price target.
Yahoo · Sep 21, 2026
Over the past six months, Merit Medical Systems has been a great trade, beating the S&P 500 by 9.1%. Its stock price has climbed to $85.50, representing a healthy 25.5% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Benzinga · Feb 26, 2026
Wells Fargo analyst Larry Biegelsen downgrades Merit Medical Systems (NASDAQ:MMSI) from Overweight to Equal-Weight and lowers the price target from $95 to $78.
Yahoo · Feb 25, 2026
MMSI beats Q4 estimates as EPS climbs 12% and margins widen, driven by strong Cardiovascular growth and solid U.S. and EMEA sales.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning MMSI.